Shortening of time-to-peak left ventricular pressure rise (Td) in cardiac resynchronization therapy
Hans Henrik Odland, Manuel Villegas-Martinez, Stian Ross, Torbjørn Holm, Richard Cornelussen, Espen W Remme, Erik Kongsgard, Hans Henrik Odland, Manuel Villegas-Martinez, Stian Ross, Torbjørn Holm, Richard Cornelussen, Espen W Remme, Erik Kongsgard
Abstract
Aims: We tested the hypothesis that shortening of time-to-peak left ventricular pressure rise (Td) reflect resynchronization in an animal model and that Td measured in patients will be helpful to identify long-term volumetric responders [end-systolic volume (ESV) decrease >15%] in cardiac resynchronization therapy (CRT).
Methods: Td was analysed in an animal study (n = 12) of left bundle-branch block (LBBB) with extensive instrumentation to detect left ventricular myocardial deformation, electrical activation, and pressures during pacing. The sum of electrical delays from the onset of pacing to four intracardiac electrodes formed a synchronicity index (SI). Pacing was performed at baseline, with LBBB, right and left ventricular pacing and finally with biventricular pacing (BIVP). We then studied Td at baseline and with BIVP in a clinical observational study in 45 patients during the implantation of CRT and followed up for up to 88 months.
Results: We found a strong relationship between Td and SI in the animals (R = 0.84, P < 0.01). Td and SI increased from narrow QRS at baseline (Td = 95 ± 2 ms, SI = 141 ± 8 ms) to LBBB (Td = 125 ± 2 ms, SI = 247 ± 9 ms, P < 0.01), and shortened with biventricular pacing (BIVP) (Td = 113 ± 2 ms and SI = 192 ± 7 ms, P < 0.01). Prolongation of Td was associated with more wasted deformation during the preejection period (R = 0.77, P < 0.01). Six patients increased ESV by 2.5 ± 18%, while 37 responders (85%) had a mean ESV decrease of 40 ± 15% after more than 6 months of follow-up. Responders presented with a higher Td at baseline than non-responders (163 ± 26 ms vs. 121 ± 19 ms, P < 0.01). Td decreased to 156 ± 16 ms (P = 0.02) with CRT in responders, while in non-responders, Td increased to 148 ± 21 ms (P < 0.01). A decrease in Td with BIVP to values similar or below what was found at baseline accurately identified responders to therapy (AUC 0.98, P < 0.01). Td at baseline and change in Td from baseline was linear related to the decrease in ESV at follow-up. All-cause mortality was high among six non-responders (n = 4), while no patients died in the responder group during follow-up.
Conclusions: Prolongation of Td is associated with cardiac dyssynchrony and more wasted deformation during the preejection period. Shortening of a prolonged Td with CRT in patients accurately identifies volumetric responders to CRT with incremental value on top of current guidelines and practices. Thus, Td carries the potential to become a biomarker to predict long-term volumetric response in CRT candidates.
Keywords: Cardiac resynchronization therapy; Reverse volumetric remodelling; Time-to-peak dP/dt.
Conflict of interest statement
None declared.
H.H.O. had an honorary from Abbott Medical, Stockholder Pacertool, and patent applications within the field of cardiac resynchronization therapy. R.C. is an employee of Medtronic Inc, Stockholder Medtronic Inc. T.H. and E.K. have no conflict of interest.
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Figures
References
- Barra S, Duehmke R, Providencia R, Narayanan K, Reitan C, Roubicek T, Polasek R, Chow A, Defaye P, Fauchier L, Piot O, Deharo JC, Sadoul N, Klug D, Garcia R, Dockrill S, Virdee M, Pettit S, Agarwal S, Borgquist R, Marijon E, Boveda S. Very long‐term survival and late sudden cardiac death in cardiac resynchronization therapy patients. Eur Heart J. 2019; 40: 2121–2127.
- Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund L, Donal E, Boriani G, Jaarsma T, Berruezo A, Traykov V, Yousef Z, Kalarus Z, Nielsen JC, Steffel J, Vardas P, Coats A, Seferovic P, Edvardsen T, Heidbuchel H, Ruschitzka F, Leclercq C. Optimized Implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. Eur J Heart Fail 2020; 22: 2349–2369.
- Leyva F, Zegard A, Okafor O, de Bono J, McNulty D, Ahmed A, Marshall H, Ray D, Qiu T. Survival after cardiac resynchronization therapy: results from 50 084 implantations. Europace. 2019; 21: 754–762.
- Biton Y, Kutyifa V, Cygankiewicz I, Goldenberg I, Klein H, McNitt S, Polonsky B, Ruwald AC, Ruwald MH, Moss AJ, Zareba W. Relation of QRS duration to clinical benefit of cardiac resynchronization therapy in mild heart failure patients without left bundle branch block: the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy substudy. Circ Heart Fail. 2016; 9: e002667.
- Goldstein RE, Haigney MC, Krone RJ, McNitt S, Zareba W, Moss AJ. Differing effects of cardiac resynchronization therapy on long‐term mortality in patient subgroups of MADIT‐CRT defined by baseline conduction and 1‐year post‐treatment left ventricular remodeling. Heart Rhythm. 2013; 10: 366–373.
- Naqvi SY, Jawaid A, Vermilye K, Biering‐Sorensen T, Goldenberg I, Zareba W, McNitt S, Polonsky B, Solomon SD, Kutyifa V. Left ventricular reverse remodeling in cardiac resynchronization therapy and long‐term outcomes. JACC Clin Electrophysiol. 2019; 5: 1001–1010.
- Kawata H, Bao H, Curtis JP, Minges KE, Mitiku T, Birgersdotter‐Green U, Feld GK, Hsu JC. Cardiac resynchronization defibrillator therapy for nonspecific intraventricular conduction delay versus right bundle branch block. J Am Coll Cardiol. 2019; 73: 3082–3099.
- Leyva F, Nisam S, Auricchio A. 20 years of cardiac resynchronization therapy. J Am Coll Cardiol. 2014; 64: 1047–1058.
- Salden OAE, Vernooy K, van Stipdonk AMW, Cramer MJ, Prinzen FW, Meine M. Strategies to improve selection of patients without typical left bundle branch block for cardiac resynchronization therapy. JACC Clin Electrophysiol. 2020; 6: 129–142.
- Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA. Myocardial strain by doppler echocardiography. validation of a new method to quantify regional myocardial function. Circulation 2000; 102: 1158–1164.
- Liu L, Tockman B, Girouard S, Pastore J, Walcott G, KenKnight B, Spinelli J. Left ventricular resynchronization therapy in a canine model of left bundle branch block. Am J Physiol Heart Circ Physiol 2002; 282: H2238–H2244.
- Vecera J, Penicka M, Eriksen M, Russell K, Bartunek J, Vanderheyden M, Smiseth OA. Wasted septal work in left ventricular dyssynchrony: a novel principle to predict response to cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging 2016; 17: 624–632.
- Strauss DG, Selvester RH, Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol 2011; 107: 927–934.
- Jang H, Conklin DJ, Kong M. Piecewise nonlinear mixed‐effects models for modeling cardiac function and assessing treatment effects. Comput Methods Programs Biomed 2013; 110: 240–252.
- Wiggers CJ. The muscular reactions of the mammalian ventricles to artificial surface stimuli. Am J Physiol‐Legacy Content 1925; 73: 346–378.
- Remme EW, Niederer S, Gjesdal O, Russell K, Hyde ER, Smith N, Smiseth OA. Factors determining the magnitude of the pre‐ejection leftward septal motion in left bundle branch block. Europace 2016; 18: 1905–1913.
- Byrne MJ, Helm RH, Daya S, Osman NF, Halperin HR, Berger RD, Kass DA, Lardo AC. Diminished left ventricular dyssynchrony and impact of resynchronization in failing hearts with right versus left bundle branch block. J Am Coll Cardiol 2007; 50: 1484–1490.
- De Boeck BW, Teske AJ, Meine M, Leenders GE, Cramer MJ, Prinzen FW, Doevendans PA. Septal rebound stretch reflects the functional substrate to cardiac resynchronization therapy and predicts volumetric and neurohormonal response. Eur J Heart Fail. 2009; 11: 863–871.
- Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol. 1999; 33: 1735–1742.
- Brady AJ. Onset of contractility in cardiac muscle. J Physiol 1966; 184: 560–580.
- Remme EW, Lyseggen E, Helle‐Valle T, Opdahl A, Pettersen E, Vartdal T, Ragnarsson A, Ljosland M, Ihlen H, Edvardsen T, Smiseth OA. Mechanisms of preejection and postejection velocity spikes in left ventricular myocardium: interaction between wall deformation and valve events. Circulation 2008; 118: 373–380.
- Russell K, Smiseth OA, Gjesdal O, Qvigstad E, Norseng PA, Sjaastad I, Opdahl A, Skulstad H, Edvardsen T, Remme EW. Mechanism of prolonged electromechanical delay in late activated myocardium during left bundle branch block. Am J Physiol Heart Circ Physiol 2011; 301: H2334–H2343.
- Adler D, Monrad ES, Hess OM, Krayenbuehl HP, Sonnenblick EH. Time to dP/dt (max), a useful index for evaluation of contractility in the catheterization laboratory. Clin Cardiol. 1996; 19: 397–403.
- Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008; 117: 2608–2616.
- Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L. Tavazzi L and Cardiac Resynchronization‐Heart Failure Study I. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352: 1539–1549.
- Bordachar P, Lafitte S, Reant P, Reuter S, Clementy J, Mletzko RU, Siegel RM, Goscinska‐Bis K, Bowes R, Morgan J, Benard S, Leclercq C. Low value of simple echocardiographic indices of ventricular dyssynchrony in predicting the response to cardiac resynchronization therapy. Eur J Heart Fail. 2010; 12: 588–592.
- Cazeau S, Ritter P, Lazarus A, Gras D, Backdach H, Mundler O, Mugica J. Multisite pacing for end‐stage heart failure: early experience. Pacing Clin Electrophysiol: PACE. 1996; 19: 1748–1757.
- Moubarak G, Ritter P, Daubert JC, Cazeau S. First experience of intraoperative echocardiography‐guided optimization of cardiac resynchronization therapy delivery. Arch Cardiovasc Dis 2014; 107: 169–177.
- Moubarak G, Viart G, Anselme F. Acute correction of electromechanical dyssynchrony and response to cardiac resynchronization therapy. ESC Heart Fail. 2020; 7: 1302–1308.
- Cazeau S, Bordachar P, Jauvert G, Lazarus A, Alonso C, Vandrell MC, Mugica J, Ritter P. Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin Electrophysiol: PACE. 2003; 26: 137–143.
- Stabile G, Pepi P, Palmisano P, D'Onofrio A, De Simone A, Caico SI, Pecora D, Rapacciuolo A, Arena G, Marini M, Pieragnoli P, Badolati S, Savarese G, Maglia G, Iuliano A, Botto GL, Malacrida M, Bertaglia E. Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real‐world population of heart failure patients requiring cardiac resynchronization therapy. Heart Rhythm. 2018; 15: 1675–1682.
- Stockburger M, Moss AJ, Klein HU, Zareba W, Goldenberg I, Biton Y, McNitt S, Kutyifa V. Sustained clinical benefit of cardiac resynchronization therapy in non‐LBBB patients with prolonged PR‐interval: MADIT‐CRT long‐term follow‐up. Clin Res Cardiol 2016; 105: 944–952.
- Duchenne J, Aalen JM, Cvijic M, Larsen CK, Galli E, Bezy S, Beela AS, Unlu S, Pagourelias ED, Winter S, Hopp E, Kongsgard E, Donal E, Fehske W, Smiseth OA, Voigt JU. Acute redistribution of regional left ventricular work by cardiac resynchronization therapy determines long‐term remodelling. Eur Heart J Cardiovasc Imaging 2020; 21: 619–628.
- Salden OAE, Zweerink A, Wouters P, Allaart CP, Geelhoed B, de Lange FJ, Maass AH, Rienstra M, Vernooy K, Vos MA, Meine M, Prinzen FW, Cramer MJ. The value of septal rebound stretch analysis for the prediction of volumetric response to cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging 2021; 22: 37–45.
- Wouters PC, Leenders GE, Cramer MJ, Meine M, Prinzen FW, Doevendans PA, De Boeck BWL. Acute recoordination rather than functional hemodynamic improvement determines reverse remodelling by cardiac resynchronisation therapy. Int J Cardiovasc Imaging 2021.
- Aalen JM, Remme EW, Larsen CK, Andersen OS, Krogh M, Duchenne J, Hopp E, Ross S, Beela AS, Kongsgaard E, Bergsland J, Odland HH, Skulstad H, Opdahl A, Voigt JU, Smiseth OA. Mechanism of abnormal septal motion in left bundle branch block: role of left Ventricular Wall interactions and myocardial scar. JACC Cardiovasc Imaging 2019; 12: 2402–2413.
- Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J, Echo CRTSG. Cardiac‐resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013; 369: 1395–1405.
- Derval N, Bordachar P, Lim HS, Sacher F, Ploux S, Laborderie J, Steendijk P, Deplagne A, Ritter P, Garrigue S, Denis A, Hocini M, Haissaguerre M, Clementy J, Jais P. Impact of pacing site on QRS duration and its relationship to hemodynamic response in cardiac resynchronization therapy for congestive heart failure. J Cardiovasc Electrophysiol 2014; 25: 1012–1020.
- Ploux S, Eschalier R, Whinnett ZI, Lumens J, Derval N, Sacher F, Hocini M, Jais P, Dubois R, Ritter P, Haissaguerre M, Wilkoff BL, Francis DP, Bordachar P. Electrical dyssynchrony induced by biventricular pacing: implications for patient selection and therapy improvement. Heart Rhythm. 2015; 12: 782–791.
- Vidula H, Kutyifa V, McNitt S, Goldenberg I, Solomon SD, Moss AJ, Zareba W. Long‐term survival of patients with left bundle branch block who are hypo‐responders to cardiac resynchronization therapy. Am J Cardiol 2017; 120: 825–830.
- Korantzopoulos P, Zhang Z, Li G, Fragakis N, Liu T. Meta‐analysis of the usefulness of change in QRS width to predict response to cardiac resynchronization therapy. Am J Cardiol 2016; 118: 1368–1373.
- Okafor O, Zegard A, van Dam P, Stegemann B, Qiu T, Marshall H, Leyva F. Changes in QRS area and QRS duration after cardiac resynchronization therapy predict cardiac mortality, heart failure hospitalizations, and ventricular arrhythmias. J Am Heart Assoc 2019; 8: e013539.
- Rickard J, Baranowski B, Grimm RA, Niebauer M, Varma N, Tang WHW, Wilkoff BL. Left ventricular size does not modify the effect of QRS duration in predicting response to cardiac resynchronization therapy. Pacing Clin Electrophysiol: PACE 2017; 40: 482–487.
- Varma N, Lappe J, He J, Niebauer M, Manne M, Tchou P. Sex‐specific response to cardiac resynchronization therapy: effect of left ventricular size and QRS duration in left bundle branch block. JACC Clin Electrophysiol 2017; 3: 844–853.
- Poole JE, Singh JP, Birgersdotter‐Green U. QRS duration or QRS morphology: what really matters in cardiac resynchronization Therapy? J Am Coll Cardiol 2016; 67: 1104–1117.
- van der Bijl P, Khidir M, Leung M, Mertens B, Ajmone Marsan N, Delgado V, Bax JJ. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy. Eur J Heart Fail 2017; 19: 1145–1151.
- Fudim M, Dalgaard F, Al‐Khatib SM, Friedman DJ, Lallinger K, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Schaber DE, Tang A, Ali‐Ahmed F, Goldstein SA, Kaufman B, Fortman R, Davis JK, Inoue LYT, Sanders GD. Future research prioritization in cardiac resynchronization therapy. Am Heart J. 2020; 223: 48–58.
Source: PubMed